These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 4816755)
41. Targeted treatment strategies for menstrual migraine. Martin V J Fam Pract; 2007 Feb; 56(2 Suppl Pain):13-22. PubMed ID: 17270114 [No Abstract] [Full Text] [Related]
42. [Study of therpaeutic indications of Ro 4-8347]. Guéguen J Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):526-40. PubMed ID: 5510178 [No Abstract] [Full Text] [Related]
43. A new method to regulate the female reproductive cycle--therapeutic indications. Smith G Pac Med Surg; 1965; 73(6):408-12. PubMed ID: 5847210 [No Abstract] [Full Text] [Related]
44. [Clinical interpretation of pregnandiol determination during the menstrual cycle and its value in hormone therapy]. KAISER R Geburtshilfe Frauenheilkd; 1952 Nov; 12(11):1006-14. PubMed ID: 13021455 [No Abstract] [Full Text] [Related]
45. Significance of Hormofort therapy and hormone-cytological examinations in cyclic disorders in puberty. Boros S; Molnár G Ther Hung; 1969; 17(1):30-5. PubMed ID: 5807605 [No Abstract] [Full Text] [Related]
46. [Treatment of functional uterine hemorrhage and luteinic insufficiency with vinylestrenolone]. Rubio LB Minerva Ginecol; 1965 Nov; 17(21):1061-3. PubMed ID: 5880760 [No Abstract] [Full Text] [Related]
47. [Treatment of ovarian dysfunction in sideropenic anemia due to hypermenorrhea]. Stanisavljevic B; Prokić N; Tir V Srp Arh Celok Lek; 1975; 103(12):1125-8. PubMed ID: 1241927 [No Abstract] [Full Text] [Related]
48. [Is it justified to give a massive dose of follicular hormone to induce ovulation? Problems of the origin of a positive estrogen feedback mechanism]. Foukas M Zentralbl Gynakol; 1972 Feb; 94(6):177-81. PubMed ID: 5023015 [TBL] [Abstract][Full Text] [Related]
49. The investigation of oligomenorrhoea and secondary amenorrhoea. Oystragh P Med J Aust; 1970 Jan; 1(4):178-81. PubMed ID: 5434885 [No Abstract] [Full Text] [Related]
51. [Therapeutic indications and results of 8080 CB in gynecology]. Girard M Rev Fr Gynecol Obstet; 1965 Apr; 60(4):281-93. PubMed ID: 5889838 [No Abstract] [Full Text] [Related]
52. Regulation of disorders of the female cycle. Lauritzen C Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):463-5. PubMed ID: 4928538 [No Abstract] [Full Text] [Related]
53. [Risk of inappropriate use of progestagens in treatment of uterine dysfunctional bleeding in adolescent girls]. Teter J; Jedrzejewski M Pol Tyg Lek; 1971 Apr; 26(17):635-8. PubMed ID: 5092301 [No Abstract] [Full Text] [Related]
54. [Antiestrogenic properties of progestagens from the therapeutical aspect of functional bleeding]. Rudel HW; Kincl FA Cesk Gynekol; 1966 Feb; 31(1):82-5. PubMed ID: 5930113 [No Abstract] [Full Text] [Related]
55. [Should the menopause be treated ? When and how? (author's transl)]. Soria R Sem Hop; 1980 Sep 18-25; 56(33-36):1374-9. PubMed ID: 6252629 [TBL] [Abstract][Full Text] [Related]
56. [Problems of today in the field of endocrinology of reproduction]. Lunenfeld B; Forleo R; Lamprecht S Riv Ostet Ginecol; 1965 May; 20(5):303-32. PubMed ID: 5828861 [No Abstract] [Full Text] [Related]
57. [1st results with the ethynodiol diacetate-mestranol combination]. Mancuso S Minerva Ginecol; 1966 Apr; 18(8):433-7. PubMed ID: 5920234 [No Abstract] [Full Text] [Related]
60. [On the effectiveness of a new gestagen in the treatment of bleeding anomalies. A clinical contribution to the problem of oral gestagen therapie]. Thewanger W Wien Klin Wochenschr; 1965 Jun; 77(25):468-9. PubMed ID: 5319349 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]